Patients with major depressive disorder exhibit reduced reward size coding in the striatum
Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MD...
Gespeichert in:
Veröffentlicht in: | Progress in neuro-psychopharmacology & biological psychiatry 2017-10, Vol.79 (Pt B), p.317-323 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 323 |
---|---|
container_issue | Pt B |
container_start_page | 317 |
container_title | Progress in neuro-psychopharmacology & biological psychiatry |
container_volume | 79 |
creator | Takamura, Masahiro Okamoto, Yasumasa Okada, Go Toki, Shigeru Yamamoto, Tetsuya Ichikawa, Naho Mori, Asako Minagawa, Hideaki Takaishi, Yoshiyuki Fujii, Yasutaka Kaichi, Yoko Akiyama, Yuji Awai, Kazuo Yamawaki, Shigeto |
description | Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted.
Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI.
In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms.
Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients.
•The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship. |
doi_str_mv | 10.1016/j.pnpbp.2017.07.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1920199660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584617300660</els_id><sourcerecordid>1920199660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</originalsourceid><addsrcrecordid>eNp9kE9PGzEQxa0K1KS0n6BS5SOXhLF3Ge8eOFSIQqVIcIALF8trzzaOsn-wvUnLp8c00GOlkd4c3pvR-zH2VcBSgMCzzXLsx2ZcShBqCXkAP7C5qFS1KKXAIzYHmffzqsQZ-xTjBgBEAcVHNpOVgnOFOGePdyZ56lPke5_WvDObIXBHY6AY_Y6483EIjgKn32vf-MQDucmSy7o3wfHon4nbwfn-F_c9T2viMQVv0tR9Zset2Ub68qYn7OHH1f3lzWJ1e_3z8vtqYUso00JB3VamxbJum4bIIUrM9Qo0kmqJjVNKlgYLI5SULShSNYrK2VIa6wrRFifs9HB3DMPTRDHpzkdL263paZiiFnUmVNeIkK3FwWrDEGOgVo_Bdyb80QL0K1S90X-h6leoGvIA5tS3twdT05H7l3mnmA0XBwPlmjtPQUeboWZMPpBN2g3-vw9eAG8uilQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920199660</pqid></control><display><type>article</type><title>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Takamura, Masahiro ; Okamoto, Yasumasa ; Okada, Go ; Toki, Shigeru ; Yamamoto, Tetsuya ; Ichikawa, Naho ; Mori, Asako ; Minagawa, Hideaki ; Takaishi, Yoshiyuki ; Fujii, Yasutaka ; Kaichi, Yoko ; Akiyama, Yuji ; Awai, Kazuo ; Yamawaki, Shigeto</creator><creatorcontrib>Takamura, Masahiro ; Okamoto, Yasumasa ; Okada, Go ; Toki, Shigeru ; Yamamoto, Tetsuya ; Ichikawa, Naho ; Mori, Asako ; Minagawa, Hideaki ; Takaishi, Yoshiyuki ; Fujii, Yasutaka ; Kaichi, Yoko ; Akiyama, Yuji ; Awai, Kazuo ; Yamawaki, Shigeto</creatorcontrib><description>Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted.
Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI.
In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms.
Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients.
•The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2017.07.006</identifier><identifier>PMID: 28705766</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adult ; Anhedonia ; Anhedonia - drug effects ; Anhedonia - physiology ; Anticipation, Psychological - drug effects ; Anticipation, Psychological - physiology ; Antidepressive Agents, Second-Generation - therapeutic use ; Brain Mapping ; Citalopram - therapeutic use ; Corpus Striatum - diagnostic imaging ; Corpus Striatum - drug effects ; Corpus Striatum - physiopathology ; Depressive Disorder, Major - diagnostic imaging ; Depressive Disorder, Major - drug therapy ; Depressive Disorder, Major - physiopathology ; Depressive Disorder, Major - psychology ; Female ; fMRI ; Humans ; Magnetic Resonance Imaging ; Major depressive disorder ; Male ; Monetary incentive delay task ; Neuropsychological Tests ; Reaction Time ; Reward ; Serotonin Uptake Inhibitors - therapeutic use ; Striatum ; Treatment Outcome</subject><ispartof>Progress in neuro-psychopharmacology & biological psychiatry, 2017-10, Vol.79 (Pt B), p.317-323</ispartof><rights>2017 The Authors</rights><rights>Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</citedby><cites>FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</cites><orcidid>0000-0002-5039-2546</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2017.07.006$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28705766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takamura, Masahiro</creatorcontrib><creatorcontrib>Okamoto, Yasumasa</creatorcontrib><creatorcontrib>Okada, Go</creatorcontrib><creatorcontrib>Toki, Shigeru</creatorcontrib><creatorcontrib>Yamamoto, Tetsuya</creatorcontrib><creatorcontrib>Ichikawa, Naho</creatorcontrib><creatorcontrib>Mori, Asako</creatorcontrib><creatorcontrib>Minagawa, Hideaki</creatorcontrib><creatorcontrib>Takaishi, Yoshiyuki</creatorcontrib><creatorcontrib>Fujii, Yasutaka</creatorcontrib><creatorcontrib>Kaichi, Yoko</creatorcontrib><creatorcontrib>Akiyama, Yuji</creatorcontrib><creatorcontrib>Awai, Kazuo</creatorcontrib><creatorcontrib>Yamawaki, Shigeto</creatorcontrib><title>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</title><title>Progress in neuro-psychopharmacology & biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted.
Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI.
In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms.
Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients.
•The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.</description><subject>Adult</subject><subject>Anhedonia</subject><subject>Anhedonia - drug effects</subject><subject>Anhedonia - physiology</subject><subject>Anticipation, Psychological - drug effects</subject><subject>Anticipation, Psychological - physiology</subject><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>Brain Mapping</subject><subject>Citalopram - therapeutic use</subject><subject>Corpus Striatum - diagnostic imaging</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - physiopathology</subject><subject>Depressive Disorder, Major - diagnostic imaging</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Depressive Disorder, Major - physiopathology</subject><subject>Depressive Disorder, Major - psychology</subject><subject>Female</subject><subject>fMRI</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Major depressive disorder</subject><subject>Male</subject><subject>Monetary incentive delay task</subject><subject>Neuropsychological Tests</subject><subject>Reaction Time</subject><subject>Reward</subject><subject>Serotonin Uptake Inhibitors - therapeutic use</subject><subject>Striatum</subject><subject>Treatment Outcome</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9PGzEQxa0K1KS0n6BS5SOXhLF3Ge8eOFSIQqVIcIALF8trzzaOsn-wvUnLp8c00GOlkd4c3pvR-zH2VcBSgMCzzXLsx2ZcShBqCXkAP7C5qFS1KKXAIzYHmffzqsQZ-xTjBgBEAcVHNpOVgnOFOGePdyZ56lPke5_WvDObIXBHY6AY_Y6483EIjgKn32vf-MQDucmSy7o3wfHon4nbwfn-F_c9T2viMQVv0tR9Zset2Ub68qYn7OHH1f3lzWJ1e_3z8vtqYUso00JB3VamxbJum4bIIUrM9Qo0kmqJjVNKlgYLI5SULShSNYrK2VIa6wrRFifs9HB3DMPTRDHpzkdL263paZiiFnUmVNeIkK3FwWrDEGOgVo_Bdyb80QL0K1S90X-h6leoGvIA5tS3twdT05H7l3mnmA0XBwPlmjtPQUeboWZMPpBN2g3-vw9eAG8uilQ</recordid><startdate>20171003</startdate><enddate>20171003</enddate><creator>Takamura, Masahiro</creator><creator>Okamoto, Yasumasa</creator><creator>Okada, Go</creator><creator>Toki, Shigeru</creator><creator>Yamamoto, Tetsuya</creator><creator>Ichikawa, Naho</creator><creator>Mori, Asako</creator><creator>Minagawa, Hideaki</creator><creator>Takaishi, Yoshiyuki</creator><creator>Fujii, Yasutaka</creator><creator>Kaichi, Yoko</creator><creator>Akiyama, Yuji</creator><creator>Awai, Kazuo</creator><creator>Yamawaki, Shigeto</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5039-2546</orcidid></search><sort><creationdate>20171003</creationdate><title>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</title><author>Takamura, Masahiro ; Okamoto, Yasumasa ; Okada, Go ; Toki, Shigeru ; Yamamoto, Tetsuya ; Ichikawa, Naho ; Mori, Asako ; Minagawa, Hideaki ; Takaishi, Yoshiyuki ; Fujii, Yasutaka ; Kaichi, Yoko ; Akiyama, Yuji ; Awai, Kazuo ; Yamawaki, Shigeto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Anhedonia</topic><topic>Anhedonia - drug effects</topic><topic>Anhedonia - physiology</topic><topic>Anticipation, Psychological - drug effects</topic><topic>Anticipation, Psychological - physiology</topic><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>Brain Mapping</topic><topic>Citalopram - therapeutic use</topic><topic>Corpus Striatum - diagnostic imaging</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - physiopathology</topic><topic>Depressive Disorder, Major - diagnostic imaging</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Depressive Disorder, Major - physiopathology</topic><topic>Depressive Disorder, Major - psychology</topic><topic>Female</topic><topic>fMRI</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Major depressive disorder</topic><topic>Male</topic><topic>Monetary incentive delay task</topic><topic>Neuropsychological Tests</topic><topic>Reaction Time</topic><topic>Reward</topic><topic>Serotonin Uptake Inhibitors - therapeutic use</topic><topic>Striatum</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takamura, Masahiro</creatorcontrib><creatorcontrib>Okamoto, Yasumasa</creatorcontrib><creatorcontrib>Okada, Go</creatorcontrib><creatorcontrib>Toki, Shigeru</creatorcontrib><creatorcontrib>Yamamoto, Tetsuya</creatorcontrib><creatorcontrib>Ichikawa, Naho</creatorcontrib><creatorcontrib>Mori, Asako</creatorcontrib><creatorcontrib>Minagawa, Hideaki</creatorcontrib><creatorcontrib>Takaishi, Yoshiyuki</creatorcontrib><creatorcontrib>Fujii, Yasutaka</creatorcontrib><creatorcontrib>Kaichi, Yoko</creatorcontrib><creatorcontrib>Akiyama, Yuji</creatorcontrib><creatorcontrib>Awai, Kazuo</creatorcontrib><creatorcontrib>Yamawaki, Shigeto</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takamura, Masahiro</au><au>Okamoto, Yasumasa</au><au>Okada, Go</au><au>Toki, Shigeru</au><au>Yamamoto, Tetsuya</au><au>Ichikawa, Naho</au><au>Mori, Asako</au><au>Minagawa, Hideaki</au><au>Takaishi, Yoshiyuki</au><au>Fujii, Yasutaka</au><au>Kaichi, Yoko</au><au>Akiyama, Yuji</au><au>Awai, Kazuo</au><au>Yamawaki, Shigeto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</atitle><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2017-10-03</date><risdate>2017</risdate><volume>79</volume><issue>Pt B</issue><spage>317</spage><epage>323</epage><pages>317-323</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted.
Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI.
In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms.
Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients.
•The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>28705766</pmid><doi>10.1016/j.pnpbp.2017.07.006</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5039-2546</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-5846 |
ispartof | Progress in neuro-psychopharmacology & biological psychiatry, 2017-10, Vol.79 (Pt B), p.317-323 |
issn | 0278-5846 1878-4216 |
language | eng |
recordid | cdi_proquest_miscellaneous_1920199660 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Anhedonia Anhedonia - drug effects Anhedonia - physiology Anticipation, Psychological - drug effects Anticipation, Psychological - physiology Antidepressive Agents, Second-Generation - therapeutic use Brain Mapping Citalopram - therapeutic use Corpus Striatum - diagnostic imaging Corpus Striatum - drug effects Corpus Striatum - physiopathology Depressive Disorder, Major - diagnostic imaging Depressive Disorder, Major - drug therapy Depressive Disorder, Major - physiopathology Depressive Disorder, Major - psychology Female fMRI Humans Magnetic Resonance Imaging Major depressive disorder Male Monetary incentive delay task Neuropsychological Tests Reaction Time Reward Serotonin Uptake Inhibitors - therapeutic use Striatum Treatment Outcome |
title | Patients with major depressive disorder exhibit reduced reward size coding in the striatum |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T13%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%20with%20major%20depressive%20disorder%20exhibit%20reduced%20reward%20size%20coding%20in%20the%20striatum&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Takamura,%20Masahiro&rft.date=2017-10-03&rft.volume=79&rft.issue=Pt%20B&rft.spage=317&rft.epage=323&rft.pages=317-323&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2017.07.006&rft_dat=%3Cproquest_cross%3E1920199660%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1920199660&rft_id=info:pmid/28705766&rft_els_id=S0278584617300660&rfr_iscdi=true |